| 标题 |
 Lessons learned in linking PROTACs from discovery to the clinic |
| 网址 | |
| DOI |
暂未提供，该求助的时间将会延长，查看原因？
|
| 其它 | Targeted protein degradation has the potential to deliver greater efficacy than conventional receptor antagonists or enzyme inhibitors and address previously undruggable targets. This has driven a recent surge of interest in protein degradation modalities. Bifunctional degraders, specifically proteolysis targeting chimeras (PROTACs), have become a key modality in the protein degrader space, despite the physicochemical challenges they present in achieving oral bioavailability. In this Review, we discuss the lessons learned to date in the optimization of PROTACs, with particular emphasis on the role of the linker region, including its role in optimization of pharmacology, impact on oral bioavailability, and influence on metabolic fate. The evolution from pharmacological tools to an established clinical modality, and the lessons that can be drawn from the preclinical data and the first cohort of PROTACs to reach the clinic, is discussed. |
| 求助人 | |
| 下载 | 求助已完成，仅限求助人下载。 |
|
温馨提示：该文献已被科研通 学术中心 收录，前往查看
科研通『学术中心』是文献索引库，收集文献的基本信息（如标题、摘要、期刊、作者、被引量等），不提供下载功能。如需下载文献全文，请通过文献求助获取。
|
PDF的下载单位、IP信息已删除
(2025-6-4)
无极微光
浮游
BowieHuang
在这无人的城堡肆无忌惮的奔跑
ZeKaWa
null
昏睡的蟠桃
Criminology34
懒骨头兄
Leonardi
zhonglv7
spc68
猪猪hero
彭于彦祖
Apricity
LewisAcid
iNk
一一
36456657
yznfly
Jared
pcr163
殷勤的紫槐
香蕉诗蕊
皖公网安备34019202002308
